7,293 reports of this reaction
4.6% of all DALFAMPRIDINE reports
#3 most reported adverse reaction
FALL is the #3 most commonly reported adverse reaction for DALFAMPRIDINE, manufactured by Merz Pharmaceuticals, LLC. There are 7,293 FDA adverse event reports linking DALFAMPRIDINE to FALL. This represents approximately 4.6% of all 157,067 adverse event reports for this drug.
Patients taking DALFAMPRIDINE who experience fall should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FALL is moderately reported among DALFAMPRIDINE users, representing a notable but not dominant share of adverse events.
In addition to fall, the following adverse reactions have been reported for DALFAMPRIDINE:
The following drugs have also been linked to fall in FDA adverse event reports:
FALL has been reported as an adverse event in 7,293 FDA reports for DALFAMPRIDINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FALL accounts for approximately 4.6% of all adverse event reports for DALFAMPRIDINE, making it one of the most commonly reported side effect.
If you experience fall while taking DALFAMPRIDINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.